MedTrace Logo

Evaluation of Lactobacillus Fermentum CECT5716 on the Incidence of Mastitis

NCT02203877 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 625

Last updated 2016-08-12

No results posted yet for this study

Summary

To evaluate the effect of the consumption of Lactobacillus fermentum CECT5716 on mastitis incidence.

Conditions

  • Mastitis

Interventions

DIETARY_SUPPLEMENT

Lactobacillus fermentum CECT5716

Intervention with a probiotic strain in form of a daily capsule containing 3x109cfu/capsule.

DIETARY_SUPPLEMENT

Maltodextrin

Intervention with a daily capsule containing maltodextrin as placebo

Sponsors & Collaborators

  • Biosearch S.A.

    lead INDUSTRY

Principal Investigators

  • Juristo Fonollá, PhD · Biosearch S.A.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02203877 on ClinicalTrials.gov